MentionFox
Home › funding signals › INFLAMMATIX, INC.
Form D · on the record

INFLAMMATIX — $47.42M Form D filing, November 2026

Before you sell to, join or invest in INFLAMMATIX, INC.

MentionFox check on INFLAMMATIX, INC.: only 1 source on file so far (checked 20 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/inflammatix-inc-form-d-001616

Check INFLAMMATIX, INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about INFLAMMATIX, INC.?

INFLAMMATIX, INC. filed a Form D with the Securities and Exchange Commission on 2026-11-19.

INFLAMMATIX, INC. filed a Form D notice of an exempt securities offering with the SEC on November 19, 2026. The filing reports $47.42M sold. Its industry group is Biotechnology. It names TIMOTHY SWEENEY (Executive Officer, Director), HEINER DREISMANN (Director), FLORIAN KAINZINGER (Director) (SEC Form D, November 19, 2026).

Sell to companies like INFLAMMATIX, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

INFLAMMATIX, INC. raised on Nov 19. 137 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Linework USA INC.$1.2BAI and software
Linework USA INC.$326MAI and software
Pathos AI, Inc.$238MBiotech
Galvanize Therapeutics, Inc.$136MBiotech
Tractian Inc.$106MAI and software
Check one company free All companies that raised this week

Selling to Inflammatix, Inc.? See who runs it and how to reach them, plus this week's 161 other newly funded companies.

Is this your company?

Key facts

Run the free check on INFLAMMATIX, INC. →

INFLAMMATIX, INC.

New Form D on file · 2026-11-19 · the record

$47.42M
raise on the record
D
filing
14
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2026-11-19
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
BasedSunnyvale, CALIFORNIA
CIK1801477
Accession0001231919-26-001616

Pitching, partnering or investing alongside them? See who really runs and owns INFLAMMATIX, INC.

Free to see. No signup.

What do you want to do with INFLAMMATIX, INC.?

Get the full cited report on INFLAMMATIX, INC.

What the filing shows about INFLAMMATIX, INC.

  • 14 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on INFLAMMATIX, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look INFLAMMATIX, INC. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on INFLAMMATIX, INC.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives INFLAMMATIX, INC.'s address as 540 Oakmead Pkwy, Sunnyvale, CA 94085.

What the filing says

  • Offered: $57,272,732. Sold: $47,421,597. Left to sell: $9,851,135. (filing)
  • Investors: 14 had already invested. (filing)
  • Date of first sale: April 5, 2024. (filing)
  • Types of securities: Equity; Options, warrants or other rights to acquire another security; Securities to be acquired on exercise of an option, warrant or other right; Other: Offer and sale of Series E and E-1 Preferred Stock and Common Stock issuable upon conversion thereof. Certain exchanged Common Stock were issued for shares of a specific series of Preferred Stock. Warrants to purchase Series E-2 Preferred Stock.. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters (marked as an estimate). (filing)
  • Securities that converted: the filing says “Total Amount Sold includes the conversion of SAFEs (Simple Agreement for Future Equity)” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on INFLAMMATIX, INC. See pricing

Is INFLAMMATIX, INC. a real, registered company?

INFLAMMATIX, INC. is a registered filer with the SEC (CIK 1801477) and has filed since 2026-11-19. 1 filing is on record, the latest on 2026-11-19.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs INFLAMMATIX, INC.?

INFLAMMATIX, INC.'s Form D of 2026-11-19 names TIMOTHY SWEENEY, HEINER DREISMANN, FLORIAN KAINZINGER and 4 more as its officers, directors or promoters.

How much has INFLAMMATIX, INC. raised?

Its new offerings report $47.42M sold across 1 offering, as its own filings state.

Biotechnology · by week
This raise, $47.42M, filed week of Nov 16

Trailing twelve months. 760 filings in Biotechnology, totalled by week. The dot is this raise, $47.42M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on INFLAMMATIX, INC.?

What the filing shows about INFLAMMATIX, INC.

  • 14 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on INFLAMMATIX, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on INFLAMMATIX, INC. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for INFLAMMATIX, INC.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

INFLAMMATIX, INC.: Raised $47.42M, Form D filed 2026-11-19
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/inflammatix-inc-form-d-001616
Last updated 2026-11-20
Primary record: SEC filing 1 · SEC filing 2
INFLAMMATIX raised $47.42M — SEC Form D filing, November 2026. MentionFox, 2026-11-20. https://mentionfox.com/funding/inflammatix-inc-form-d-001616